posted on 2024-08-15, 17:37authored byNicole Jimenez, Taylor Norton, Gurbeen Diadala, Emerald Bell, Michelle Valenti, Leslie V. Farland, Nichole Mahnert, Melissa M. Herbst-Kralovetz
Additional file 4: Table S20: immunoproteomic statistical results of the groups’ CPP compared to surgical controls. Table S21: immunoproteomic statistical results of the groups’ CPP-Endo compared to surgical controls. Table S22: immunoproteomic statistical results of the groups’ CPP compared to CPP-Endo. Table S23: immunoproteomic statistical results of the groups’ endometriosis stage 3/4 compared to stage 1/2. Table S24: immunoproteomic statistical results of the groups’ other endometriosis locations compared to endometriosis of the ovary. Table S25: immunoproteomic statistical results of the group endometriosis on peritoneum compared to endometriosis of the ovary. Table S26: immunoproteomic statistical results of the groups’ endometriosis at multiple locations compared to endometriosis on the ovary. Table S27: immunoproteomic statistical results of the groups’ ovarian cysts compared to no ovarian cysts. Table S28: immunoproteomic statistical results of the groups’ fibroids compared to no fibroids. Table S29: immunoproteomic statistical results of the groups’ abnormal uterine bleeding compared to no abnormal uterine bleeding. Table S30: immunoproteomic statistical results of the groups’ blood in the sample compared to no blood in the sample.
Funding
Community Foundation for Southern Arizona Valley Research Partnership Banner Health Foundation Women Inspiring Science and Health